Loading...
The move will see OxDevice Medical consolidate its existing operations from three separate buildings into a single, modern site, strengthening capacity and creating a platform for future growth. The relocation reflects Kaleidex’s continued investment in its group businesses, enabling infrastructure-led expansion while maintaining continuity for customers.
Refurbishment work at Monarch House will commence in early 2026, with office teams and R&D capabilities transferring first, followed by the completion of new cleanroom and specialist laboratory facilities. Validation activities will be completed before production resumes fully in the new facility.
Throughout the transition, OxDevice’s priority remains maintaining service continuity and avoiding disruption to customer programmes, with phased planning and proactive communication already underway, and OxDevice teams working closely with partners to manage schedules and maintain delivery commitments. OxDevice recently passed a full recertification of the whole quality system for ISO 13485 and has cleanroom certification for ISO 14644.
Gavin Meadows, Chief Executive Officer of Kaleidex, said:
“This investment demonstrates our commitment to backing the long-term growth of OxDevice. Bringing teams and capabilities together into a single, modern facility strengthens operational resilience today while creating the foundations for future capability expansion. It is a considered, practical step in our broader ambition to build factories of the future across the Kaleidex Group.”
